Clinical Trials Browser

Carcinoma, Hepatocellular × Monatide (IMS 3015) × 1 year × Clear all

NCT06218511 2025-12-22

A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)

Phase 1 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular